Cancer · 2008 · 31 citations · 28 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyProteomicsCancer ProteomicsEpithelial-mesenchymal TransitionEsophageal CancerMass Spectrometry-based ProteomicsProteomic ProfilingSquamous Cell CarcinomaCell Growth RegulationEpithelial-mesenchymal Transition In CancerMalignant ProgressionMesenchymal TransitionProteomic Data AnalysisProteomic SignaturesTumor Metastasis BiologyTumor Proteomics
BACKGROUND: By using proteomic technology, the authors previously observed the substantial down-regulation of mammary serine protease inhibitor (maspin) in esophageal squamous cell carcinoma and metastases. In the current study, they examined the effects of maspin re-expression in a maspin-null esophageal cancer cell line EC109 and also investigated the underlying mechanism. METHODS: A cell line with stable maspin expression was established. An epithelial growth factor (EGF)-induced epithelial-mesenchymal transition (EMT) model was used to mimic some aspects of the metastatic process in vitro. The effects of maspin reintroduction on EGF-induced EMT and cell growth characteristics were evaluated. Comparative proteomic analysis of transfected cells versus parental cells was then performed to explore the potential mechanism. RESULTS: The introduction of maspin into EC109 cells was able to inhibit EGF-induced EMT and altered cell growth characteristics, including the serum dependence, proliferative response to EGF stimulation, and colony formation ability in soft agar, indicating a conversion from a malignant phenotype to a benign phenotype. Proteomic analysis revealed a significant down-regulation of a group of glycolytic enzymes in maspin-transfected cells. In addition, maspin-transfected cells expressed much lower levels of hypoxia-inducible factor 1alpha than parental cells or empty vector transfected cells. CONCLUSIONS: Maspin exhibited a metastasis-suppressive effect, which may be a consequence of the reversal of the malignant phenotype of EC109 cells. The switch of cellular metabolic phenotype to low glycolysis by the gain of maspin function may play a key role in the process. This finding provides additional evidence of the tumor metastasis-suppressive activity of maspin and may indicate a new direction for future studies of the mechanism of maspin.
28
Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells
Zhiqiang Zou, Anthony Anisowicz, Mary J.C. Hendrix et al. · Science · 1994 · 917 citations
Medicine, Cancer Biology, Oncology +12
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun‐Li Luo, Wei Phin Tan, Jill M. Ricono et al. · Nature · 2007 · 439 citations